Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · May 24, 2021

1-Year Treatment Outcomes of Bevacizumab for Diabetic Macular Oedema

Eye (London, England)


Additional Info

Eye (London, England)
Bevacizumab for Diabetic Macular Oedema: One-Year Treatment Outcomes From the Fight Retinal Blindness! Registry
Eye (Lond) 2021 Mar 25;[EPub Ahead of Print], S Bhandari, D Squirrell, V Nguyen, N Wang, JM Wells, T Tan, R Barnes, R Barry, D Barthelmes, M Gillies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading